APLP2 and night blindness: Studies examining the effect of genetic ablation of APLP2 in the mouse model has led to the successful discoveries of a redundant role of APLP2 in a number of clinical diseases such as myopia [39], retinal synaptopathy, a congenital stationary night blindness condition [41] and in corneal epithelial wound healing [73].